Αποτελέσματα Αναζήτησης
1 Οκτ 2021 · Interstitial EP in a 23-year-old woman who presented with positive pregnancy test results and abdominal pain. Transverse transvaginal gray-scale US cine clip of the uterus shows an EP implanted in the interstitial portion of the right fallopian tube.
- PDF Download
Methotrexate (MTX) is the primary pharmaceutical agent that...
- PDF Download
Methotrexate (MTX) is a folate antagonist with known teratogenicity including abor-tifacient effects that interfere with DNA synthesis. We want to discuss on which find-ings teratogenicity is based and which open questions still exist.
1 Οκτ 1999 · With the increasing use of MTX in the rheumatic diseases and other inflammatory conditions, it is essential that all cases of MTX exposure in pregnancy are reported to central surveillance bodies to provide a complete picture of the teratogenicity of MTX.
Methotrexate (MTX) is a folate antagonist with known teratogenicity including abortifacient effects that interfere with DNA synthesis. We want to discuss on which findings teratogenicity is based and which open questions still exist.
15 Μαρ 2023 · In addition to the approved indications for the drug treatment of malignancies and inflammatory disorders, it is used for the non-surgical treatment of ectopic pregnancy and elective termination of pregnancy (TOP). The dose differs according to indication and also plays a role in teratology.
Methotrexate was used to induce abortions and is currently used to treat ectopic pregnancies (pregnancies that grow outside the uterus). Some brand names for methotrexate are: Otrexup®, Trexall®, Rheumatrex®, and Rasuvo®.
Results. Two hundred and eleven women (mean age 33 ± 1.8 years) with PUL were enrolled in the study, with an overall success rate of 89.1 %. Single- and double-dose MTX protocols were found to have comparable treatment success rates (93 % and 95 %, respectively).
